Serve as senior physician for CAR T-cell therapy clinical trials in autoimmune indications providing medical oversight across study design and execution.
Lead clinical development plans and study execution for neuroimmunology and autoimmune disease programs.
Contribute to scientific communication and external engagement with key opinion leaders and regulatory authorities.
Serve as commercial account lead for designated treatment centers and referral networks, driving demand and executing strategic account plans.
Build trusted relationships with key stakeholders across neurology and oncology to facilitate patient identification, referral, and treatment.
Navigate complex healthcare systems and collaborate cross-functionally to coordinate customer needs and market insights.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases. The company is guided by core values and fosters a collaborative, innovative culture focused on transforming treatment for autoimmune disease.
Provide direct consultative care to members with autoimmune conditions and supervise a growing multidisciplinary clinical team.
Develop clinical protocols, ensure quality and safety, and serve as senior clinical authority for escalations.
Build staffing models, recruit clinicians, and transition direct-care responsibilities as the program scales.
9amHealth is an AI-enabled virtual specialty care platform focused on managing high-cost chronic conditions at scale, partnering with employers and health plans. Founded in 2021, the company is backed by leading healthcare investors and operates with a collaborative, mission-driven culture across global teams.
Develop and lead integrated global regulatory strategies for I&I pipeline programs.
Serve as primary regulatory strategist and Health Authority relationship lead.
Provide expert guidance on development plan design and filing strategies.
Beeline Medicines is a clinical-stage biotechnology company developing precision therapies for autoimmune and inflammatory diseases. It is a small company backed by world-class investors, with a culture of scientific rigor and operational excellence.
Build the clinical development plan and first-in-human strategy from the ground up.
Design the Phase 1 protocol: dose, endpoints, population, pharmacodynamic readouts, and design nuance across two therapeutic areas.
Shape the translational and biomarker strategy to turn a preclinical mechanism into a credible human proof-of-mechanism readout.
Enveda is a clinical-stage, AI-enabled biotech discovering medicines four times faster than the industry standard. They recently raised $311M in a Series E, are recognized as one of America's Best Startup Employers by Forbes, and a Top 100 Most Loved Workplace by Newsweek, building a rare company with a collaborative and direct culture.